Update, November 3, 2026
Exxon Mobil (XOM) has pulled back 4.0% from its October 30 peak of $187.25, closing at $179.67 ahead of the November 3 session. The 5-day decline of 2.6% outpaced the S&P 500's 1.7% drop but was slightly better than the energy sector's 3.4% fall, per XLE. The stock's 1-month gain of +9.5% still leads both the market and sector, and it remains 9.0% above the S&P 500 over 50 days.
The picture holds. The daily trend still runs with the weekly uptrend, and the price remains above its 40-week average. The 52-week high at $187.25 is now resistance, with support at $175.00 (round) and the 50-day SMA at $168.05 — the level that would change the picture on a weekly close below. The stop from the report, $173.88, is just below the round support. The 14-day RSI at 57.6 shows the stock is no longer overbought after the pullback.
Q3 results (reported November 2) beat estimates with adjusted EPS of $4.23 and revenue of $113.16 billion, per Benzinga, which noted Wells Fargo and Evercore ISI raised targets to $189 and $200. The 10-Q filing confirmed net income up 104% year-over-year. The stock trades 1.3% below the mean analyst target of $182.05. The next earnings are January 29, 2027.
Exxon Mobil Corporation (XOM) rose about 2% in early trading on October 23, 2026 to a new 52-week high of $181.80, with no company-specific news behind the move; the energy sector did the lifting. The balance of evidence leans positive for the next two to six weeks, with high conviction (3 of 4 points), because the daily and weekly trends agree and XOM is outrunning both the S&P 500 and XLE. The cost of that strength is a stretched stock: an RSI near 85, a price above the mean analyst target, and breakout math of only 1.3 to 1.
Why it matters
There is no XOM headline that explains today's gain. The week's news came from around the industry. Bloomberg reported on October 22 that an arbitration court invalidated about $12 billion of the roughly $20 billion in disputed costs Kazakhstan had sought from oil majors at the Kashagan field, which narrows what the majors may have to pay. Separately, Bloomberg said Citgo lifted its 2026 operating profit outlook by $2 billion on surging fuel margins. For an integrated company with a large refining and chemicals arm, strong margins are the kind of evidence that supports earnings.
Little of this was a surprise to the market, because the stock had already moved. XOM is up 12.8% in a month, 20.8% in six months and 51.1% so far this year. Today's 2.0% gain arrives on top of that. Over the last five days XOM gained 1.6%, XLE gained 0.75% and the S&P 500 slipped 0.27%. So the broad market was a slight drag, the sector supplied about three quarters of a point, and XOM added another 0.8 points beyond the sector. Today the pattern is the same: XLE is up 1.75% and the S&P 500 is down 0.36%. TheStreet notes that energy is the top S&P 500 sector in 2026, with XLE up 55.4% this year and 29% since June 30, while the technology ETF is essentially flat over that stretch. XOM is part of that sector move, not a separate story.
The argument about XOM is mostly about price and peers, not direction. On the positive side, Morningstar strategist Dave Sekera names XOM, with a narrow moat, among three value stocks he likes as long-term holdings when they trade below fair value. The Motley Fool points out that XOM is up 58% over twelve months against 45% for Chevron, and that XOM has a larger downstream and chemicals business, with about 70% of profit from upstream versus about 80% at Chevron. The cooler voice is Benzinga, which relays Jim Cramer rating Chevron above XOM. That is a preference between two oil majors, not a case against the trend.
Valuation is where the caution sits. Across 22 analysts the consensus is buy, but the mean price target is $179.41, and the stock at $181.80 is 1.3% above it. The range runs from $142 to $206, so only the top of the range sits well above the current price. History offers little extra help: after 320 earlier new 52-week highs, the stock was higher a month later 63.1% of the time, against 61.8% typically, with a median one-month move of 1.36%. A new high is not, by itself, an edge.
What the evidence says
The long-term thesis is intact, and the stock is in a mature, extended phase of the advance. Price is above both its 10-week and 40-week averages, the 50-day average ($165.75) sits above the 200-day ($153.15), and the shares are 59.9% above their 52-week low of $113.68. Against the S&P 500 the lead is 10.6% over 50 days and 13.2% over 200 days. This is leadership that has lasted months, not a one-day spike.
For the next two to six weeks the balance of evidence leans positive, and conviction is high at 3 of 4 points. The reasons are specific: the daily trend runs with the weekly uptrend, XOM leads the S&P 500 over 50 days by 10.6%, and it also leads XLE over 50 days by 2.6%. Beating the sector, not just the market, matters because it shows buyers prefer XOM within an area they already favor.
The strongest case against is that the move is stretched and thinly confirmed. RSI is 84.82, which is deeply overbought. The price is above the mean analyst target. Volume so far in today's session is 87.5% below its 20-day average, though the day is not finished. And the historical odds after new highs are barely better than normal. Together these are why conviction stops at 3 of 4 and not higher. They do not tip the balance, because they describe how fast the stock has risen, not whether the trend has turned, and the trend and relative strength are both still pointing up.
Levels that matter
The structure holds above $181.8, the 52-week high, which the stock is trading at now; a close back under it would be the first crack. Below that, support stacks up at $175, the $169.14 swing zone and then $165.75, the 50-day average. The trend ends below $165.75, because that is where the average that has carried the advance would give way, with another swing zone at $164.29 just beneath it.
The breakout level is a daily close above $200.0 on volume above its 20-day average. From there the nearest target is $225.0. A breakout would be wrong below $180.85, which is the 52-week high of $181.8 less a quarter of the 3.8 daily ATR. That works out to 1.3 to 1 reward to risk, short of the 3 to 1 that makes a breakout worth the risk. Only a target well above $225 or a stop much tighter than $180.85 would lift the math to 3 to 1, and the resistance map shows nothing beyond $225.
What would change the picture
A weekly close below $165.75, the 50-day average, would change the picture: it would mean the pullback is more than a pause in a trend that has held for months. The non-price fact that would likely do it is a turn in the fuel and refining margins that have supported earnings, for example results or sector reports showing those margins rolling over just as the stock is priced above the mean analyst target.
What to watch
- Earnings on October 30, 2026: the number that matters is the split of profit between upstream and downstream, since about 70% of XOM's profit comes from upstream and margins in refining have been the swing factor.
- Sector events: XLE moved 1.75% today and 10.2% over the past month, and it tends to move XOM before the company's own news does. The central bank decisions this week, including the Federal Reserve, ECB and Bank of Japan, set the tone for the broader market (Reuters).
- Valuation: at $181.80 the stock is 1.3% above the $179.41 mean target of 22 analysts, with only the $206 high target well above it.